Evidence map›Paper›PMID 18423189›Full record

ArticleCell2008

Rethinking pseudokinases.

Natarajan Kannan, Susan S Taylor

Open access · bronzeAbstract readComment
In one paragraph

Article in Cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Kinases and pseudokinases: lessons from RAF.Molecular and cellular biology · 2014
    Review
  10. Article
  11. Pseudokinases from a structural perspective.Biochemical Society transactions · 2013
    Review
  12. An evolutionary perspective on the kinome of malaria parasites.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2012
    Review
  13. Diversity, classification and function of the plant protein kinase superfamily.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2012
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Pseudokinases-remnants of evolution or key allosteric regulators?Current opinion in structural biology · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Natarajan KannanDepartment of Chemistry, Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA 92014-6054, USA.
Susan S Taylor
Howard Hughes Medical Institute · US

Funding

Protein Kinase: Primary Structure and cAMP InteractionsR01GM019301 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1985 to 2013
$3.4M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM019301
6 · The paper itself

Abstract

Pseudokinases lack conservation of one or more of the catalytic residues in the kinase core and as a consequence are typically thought to be catalytically inactive. New work by Mukherjee et al. (2008) challenges this assumption. They show that the pseudokinase domain of CASK (Ca2+/calmodulin activated serine-threonine kinase) adopts an active conformation and displays catalytic activity in vivo.

Indexed as

Guanylate KinasesHumansPhosphorylationProtein ConformationProtein Structure, TertiaryCASK kinasesGuanylate Kinases

Identifiers

PMID18423189
PMCPMC6226312
OpenAlexW4236567810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.